Leukocyte Calpain Deficiency Reduces Angiotensin II-Induced Inflammation and Atherosclerosis But Not Abdominal Aortic Aneurysms in Mice. 2016

Deborah A Howatt, and Anju Balakrishnan, and Jessica J Moorleghen, and Latha Muniappan, and Debra L Rateri, and Haruhito A Uchida, and Jiro Takano, and Takaomi C Saido, and Athar H Chishti, and Laurent Baud, and Venkateswaran Subramanian
From the Saha Cardiovascular Research Center (D.A.H., A.B., J.J.M., L.M., D.L.R.), and Department of Physiology (V.S.), University of Kentucky, Lexington; Department of Chronic Kidney Disease and Cardiovascular Disease, Okayama University School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan (H.A.U.); Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Saitama, Japan (J.T., T.C.S.); Department of Developmental, Molecular, and Chemical Biology, Tufts University School of Medicine, Boston, MA (A.H.C.); and INSERM, Université Pierre et Marie Curie-Paris, Paris, France (L.B.).

Angiotensin II (AngII) infusion profoundly increases activity of calpains, calcium-dependent neutral cysteine proteases, in mice. Pharmacological inhibition of calpains attenuates AngII-induced aortic medial macrophage accumulation, atherosclerosis, and abdominal aortic aneurysm in mice. However, the precise functional contribution of leukocyte-derived calpains in AngII-induced vascular pathologies has not been determined. The purpose of this study was to determine whether calpains expressed in bone marrow (BM)-derived cells contribute to AngII-induced atherosclerosis and aortic aneurysms in hypercholesterolemic mice. To study whether leukocyte calpains contributed to AngII-induced aortic pathologies, irradiated male low-density lipoprotein receptor(-/-) mice were repopulated with BM-derived cells that were either wild-type or overexpressed calpastatin, the endogenous inhibitor of calpains. Mice were fed a fat-enriched diet and infused with AngII (1000 ng/kg per minute) for 4 weeks. Overexpression of calpastatin in BM-derived cells significantly attenuated AngII-induced atherosclerotic lesion formation in aortic arches, but had no effect on aneurysm formation. Using either BM-derived cells from calpain-1-deficient mice or mice with leukocyte-specific calpain-2 deficiency generated using cre-loxP recombination technology, further studies demonstrated that independent deficiency of either calpain-1 or -2 in leukocytes modestly attenuated AngII-induced atherosclerosis. Calpastatin overexpression significantly attenuated AngII-induced inflammatory responses in macrophages and spleen. Furthermore, calpain inhibition suppressed migration and adhesion of macrophages to endothelial cells in vitro. Calpain inhibition also significantly decreased hypercholesterolemia-induced atherosclerosis in the absence of AngII. The present study demonstrates a pivotal role for BM-derived calpains in mediating AngII-induced atherosclerosis by influencing macrophage function.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011973 Receptors, LDL Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. LDL Receptors,Lipoprotein LDL Receptors,Receptors, Low Density Lipoprotein,LDL Receptor,LDL Receptors, Lipoprotein,Low Density Lipoprotein Receptor,Low Density Lipoprotein Receptors,Receptors, Lipoprotein, LDL,Receptor, LDL,Receptors, Lipoprotein LDL
D002135 Calcium-Binding Proteins Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS. Calcium Binding Protein,Calcium-Binding Protein,Calcium Binding Proteins,Binding Protein, Calcium,Binding Proteins, Calcium,Protein, Calcium Binding,Protein, Calcium-Binding
D002154 Calpain Cysteine proteinase found in many tissues. Hydrolyzes a variety of endogenous proteins including NEUROPEPTIDES; CYTOSKELETAL PROTEINS; proteins from SMOOTH MUSCLE; CARDIAC MUSCLE; liver; platelets; and erythrocytes. Two subclasses having high and low calcium sensitivity are known. Removes Z-discs and M-lines from myofibrils. Activates phosphorylase kinase and cyclic nucleotide-independent protein kinase. This enzyme was formerly listed as EC 3.4.22.4. Calcium-Activated Neutral Protease,Calcium-Dependent Neutral Proteinase,Ca2+-Activated Protease,Calcium-Activated Neutral Proteinase,Calcium-Activated Protease,Calcium-Dependent Neutral Protease,Calpain I,Calpain II,Desminase,Ca2+ Activated Protease,Calcium Activated Neutral Protease,Calcium Activated Neutral Proteinase,Calcium Activated Protease,Calcium Dependent Neutral Protease,Calcium Dependent Neutral Proteinase,Neutral Protease, Calcium-Activated,Neutral Protease, Calcium-Dependent,Neutral Proteinase, Calcium-Activated,Neutral Proteinase, Calcium-Dependent,Protease, Ca2+-Activated,Protease, Calcium-Activated,Protease, Calcium-Activated Neutral,Protease, Calcium-Dependent Neutral,Proteinase, Calcium-Activated Neutral,Proteinase, Calcium-Dependent Neutral

Related Publications

Deborah A Howatt, and Anju Balakrishnan, and Jessica J Moorleghen, and Latha Muniappan, and Debra L Rateri, and Haruhito A Uchida, and Jiro Takano, and Takaomi C Saido, and Athar H Chishti, and Laurent Baud, and Venkateswaran Subramanian
April 2018, Arteriosclerosis, thrombosis, and vascular biology,
Deborah A Howatt, and Anju Balakrishnan, and Jessica J Moorleghen, and Latha Muniappan, and Debra L Rateri, and Haruhito A Uchida, and Jiro Takano, and Takaomi C Saido, and Athar H Chishti, and Laurent Baud, and Venkateswaran Subramanian
February 2005, British journal of pharmacology,
Deborah A Howatt, and Anju Balakrishnan, and Jessica J Moorleghen, and Latha Muniappan, and Debra L Rateri, and Haruhito A Uchida, and Jiro Takano, and Takaomi C Saido, and Athar H Chishti, and Laurent Baud, and Venkateswaran Subramanian
January 2016, Arteriosclerosis, thrombosis, and vascular biology,
Deborah A Howatt, and Anju Balakrishnan, and Jessica J Moorleghen, and Latha Muniappan, and Debra L Rateri, and Haruhito A Uchida, and Jiro Takano, and Takaomi C Saido, and Athar H Chishti, and Laurent Baud, and Venkateswaran Subramanian
November 2014, Arteriosclerosis, thrombosis, and vascular biology,
Deborah A Howatt, and Anju Balakrishnan, and Jessica J Moorleghen, and Latha Muniappan, and Debra L Rateri, and Haruhito A Uchida, and Jiro Takano, and Takaomi C Saido, and Athar H Chishti, and Laurent Baud, and Venkateswaran Subramanian
February 2012, Atherosclerosis,
Deborah A Howatt, and Anju Balakrishnan, and Jessica J Moorleghen, and Latha Muniappan, and Debra L Rateri, and Haruhito A Uchida, and Jiro Takano, and Takaomi C Saido, and Athar H Chishti, and Laurent Baud, and Venkateswaran Subramanian
August 2010, Atherosclerosis,
Deborah A Howatt, and Anju Balakrishnan, and Jessica J Moorleghen, and Latha Muniappan, and Debra L Rateri, and Haruhito A Uchida, and Jiro Takano, and Takaomi C Saido, and Athar H Chishti, and Laurent Baud, and Venkateswaran Subramanian
August 2022, Biomolecules,
Deborah A Howatt, and Anju Balakrishnan, and Jessica J Moorleghen, and Latha Muniappan, and Debra L Rateri, and Haruhito A Uchida, and Jiro Takano, and Takaomi C Saido, and Athar H Chishti, and Laurent Baud, and Venkateswaran Subramanian
October 2023, Scientific reports,
Deborah A Howatt, and Anju Balakrishnan, and Jessica J Moorleghen, and Latha Muniappan, and Debra L Rateri, and Haruhito A Uchida, and Jiro Takano, and Takaomi C Saido, and Athar H Chishti, and Laurent Baud, and Venkateswaran Subramanian
May 2021, Journal of the American Heart Association,
Deborah A Howatt, and Anju Balakrishnan, and Jessica J Moorleghen, and Latha Muniappan, and Debra L Rateri, and Haruhito A Uchida, and Jiro Takano, and Takaomi C Saido, and Athar H Chishti, and Laurent Baud, and Venkateswaran Subramanian
January 2022, Oxidative medicine and cellular longevity,
Copied contents to your clipboard!